Targeting eukaryotic proteases for natural products-based drug development.

Natural Product Reports
Fatma H Al-Awadhi, Hendrik Luesch

Abstract

Covering: up to April 2020 Proteases are involved in the regulation of many physiological processes. Their overexpression and dysregulated activity are linked to diseases such as hypertension, diabetes, viral infections, blood clotting disorders, respiratory diseases, and cancer. Therefore, they represent an important class of therapeutic targets. Several protease inhibitors have reached the market and >60% of them are directly related to natural products, even when excluding synthetic natural product mimics. Historically, natural products have been a valuable and validated source of therapeutic agents, as over half of the marketed drugs across targets and diseases are inspired by natural product structures. In the past two decades the number of new protease inhibitors discovered from nature has sharply increased. Additionally, the availability of 3D structural information for proteases has permitted structure-based design and accelerated the synthesis of optimized lead structures with improved potency and selectivity profiles, resulting in some of the most-potent-in-class inhibitors. These discoveries were oftentimes maximized by in-depth biological assessments of lead inhibitors, linking them to a relevant disease state. This...Continue Reading

References

Nov 1, 1992·The Journal of Antibiotics·M HanadaT Oki
Jun 14, 1991·Biochemical and Biophysical Research Communications·K KawabataT Miyamoto
Feb 1, 1995·Trends in Pharmacological Sciences·M L West, D P Fairlie
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E T BaldwinJ W Erickson
Jan 1, 1996·The Journal of Experimental Medicine·S Hess, H Engelmann
Apr 21, 1997·FEBS Letters·A FujishimaT Sugawara
May 1, 1998·The New England Journal of Medicine·C Flexner
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·L MengC M Crews
Feb 12, 2000·Journal of Medicinal Chemistry·D LeungD P Fairlie
Jul 11, 2000·Natural Product Reports·D J NewmanK M Snader
Mar 27, 2001·Acta Crystallographica. Section D, Biological Crystallography·I F BatistaR C Garratt
Jul 27, 2002·Journal of Natural Products·Alexei PloutnoShmuel Carmeli
May 2, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Charles G Smith, John R Vane
Aug 21, 2003·Biochemical and Biophysical Research Communications·Jeanette M WoodMartin P Bedigian
Oct 30, 2003·Chemistry & Biology·Ute MaternGeorg E Schulz
May 29, 2004·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Patricia Zancan, Paulo A S Mourão
Aug 3, 2004·Critical Care Medicine·Bernhardt G ZeiherUNKNOWN STRIVE Study Group
Oct 23, 2004·Journal of Natural Products·Xiuli XuJiangong Shi
May 27, 2005·Journal of Medicinal Chemistry·Venkat R MacherlaBarbara C M Potts
Jul 12, 2005·Oncogene·Ami S BhattMark M Moasser
Jul 27, 2005·Seminars in Cancer Biology·Kelly K Hunt, Khandan Keyomarsi
Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·J A Huntington
Jul 18, 2006·Nucleic Acids Research·Honglin LiHualiang Jiang
Aug 31, 2006·Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology·Yoshiyuki OkumuraToshiaki Nikai
Sep 7, 2006·Nature Reviews. Drug Discovery·Boris Turk
Nov 30, 2006·Cellular and Molecular Life Sciences : CMLS·K Uhland
Jan 30, 2007·Hematology/oncology Clinics of North America·Kenichi A Tanaka, Jerrold H Levy
Feb 9, 2007·Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology·Yoshiyuki OkumuraKei-ichi Uchiya
Feb 27, 2007·Surgical Oncology·Takashi SatoJun-ichi Yamashita
Apr 3, 2007·Neoplasia : an International Journal for Oncology Research·Miwa AkizukiJun-ichi Yamashita
Apr 25, 2007·Nature Reviews. Neuroscience·Karl Herrup, Yan Yang
Aug 1, 2007·Journal of Thrombosis and Haemostasis : JTH·J T B CrawleyD A Lane
Sep 29, 2007·Bioorganic & Medicinal Chemistry·Arun K GhoshHiroaki Mitsuya
Oct 4, 2007·Journal of Natural Products·Kanchan TaoriHendrik Luesch

❮ Previous
Next ❯

Citations

Sep 5, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Imam FathoniTatsufumi Okino
Mar 5, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Abdur RaufKannan Rr Rengasamy

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar lavage
X-ray
acetylation

Software Mentioned

TarFisDock
clog

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.